• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用恶性疟原虫的氯喹敏感和氯喹耐药菌株以及约氏疟原虫的氯喹耐药菌株对化合物的体外和体内抗疟活性之间的相关性。

Correlation between in vitro and in vivo antimalarial activity of compounds using CQ-sensitive and CQ-resistant strains of Plasmodium falciparum and CQ-resistant strain of P. yoelii.

作者信息

Srivastava Kumkum, Agarwal Pooja, Soni Awakash, Puri S K

机构信息

Parasitology Division, CSIR-Central Drug Research Institute, Sect-10, Jankipuram Extension, Sitapur Road, Lucknow, 226031, India.

Academy of Scientific and Innovative Research, New Delhi, India.

出版信息

Parasitol Res. 2017 Jul;116(7):1849-1854. doi: 10.1007/s00436-017-5455-5. Epub 2017 May 13.

DOI:10.1007/s00436-017-5455-5
PMID:28502016
Abstract

Present efforts have been made to establish a correlation between in vitro and in vivo antimalarial activity using MIC, IC and IC values against CQ-sensitive (3D7) and CQ-resistant (K1) strains of Plasmodium falciparum and in vivo activity against Plasmodium yoelii. The method of discriminant function analysis (DFA) was applied to analyze the data. It was observed that in vitro IC values against both 3D7 and K1 strains (p < 0.001) have strong correlation with in vivo curative activity. The respective IC and IC values of compounds, which cured mice (i.e., animals did not show recrudescence of parasitemia even after 60 days posttreatment), ranged between 3 and 14 nM and 14 and 186 nM against 3D7 and between 9 and 65 nM and 24 and 359 nM against the K1 strain of P. falciparum. Whereas the IC and IC values of compounds which exhibited in vivo suppressive activity in mice ranged between 10 and 307 nm and 61 and >965 nM, respectively, against 3D7 and 75 and >806 nm and 241 and >1232 nM against the K1 strain of P. falciparum. The findings suggest that IC values against both 3D7 and K1 strains (p < 0.02) are the main contributors for the prediction of in vivo curative activity of a new molecule. Apart from this, a reasonable correlation between MIC and IC values of compounds has also been established.

摘要

目前已开展相关工作,利用针对恶性疟原虫氯喹敏感株(3D7)和氯喹耐药株(K1)的最低抑菌浓度(MIC)、半数抑制浓度(IC)和IC值,以及对约氏疟原虫的体内活性,建立体外和体内抗疟活性之间的相关性。应用判别函数分析(DFA)方法对数据进行分析。结果发现,针对3D7和K1株的体外IC值(p < 0.001)与体内治疗活性具有很强的相关性。治愈小鼠(即动物在治疗后60天即使未出现寄生虫血症复发)的化合物,其针对3D7株的IC值和IC值分别在3至14 nM和14至186 nM之间,针对恶性疟原虫K1株的IC值和IC值分别在9至65 nM和24至359 nM之间。而在小鼠中表现出体内抑制活性的化合物,其针对3D7株的IC值和IC值分别在10至307 nM和61至>965 nM之间,针对恶性疟原虫K1株的IC值和IC值分别在75至>806 nM和241至>1232 nM之间。研究结果表明,针对3D7和K1株的IC值(p < 0.02)是预测新分子体内治疗活性的主要因素。除此之外,还建立了化合物MIC值和IC值之间的合理相关性。

相似文献

1
Correlation between in vitro and in vivo antimalarial activity of compounds using CQ-sensitive and CQ-resistant strains of Plasmodium falciparum and CQ-resistant strain of P. yoelii.使用恶性疟原虫的氯喹敏感和氯喹耐药菌株以及约氏疟原虫的氯喹耐药菌株对化合物的体外和体内抗疟活性之间的相关性。
Parasitol Res. 2017 Jul;116(7):1849-1854. doi: 10.1007/s00436-017-5455-5. Epub 2017 May 13.
2
susceptibility of Indian isolates to different antimalarial drugs & antibiotics.印度分离株对不同抗疟药物和抗生素的敏感性。
Indian J Med Res. 2017 Nov;146(5):622-628. doi: 10.4103/ijmr.IJMR_1688_15.
3
Antimalarial activity of novel 4-aminoquinolines active against drug resistant strains.新型 4-氨基喹啉类抗疟药对耐药株的抗疟活性。
Bioorg Chem. 2017 Feb;70:74-85. doi: 10.1016/j.bioorg.2016.11.010. Epub 2016 Nov 23.
4
Design, synthesis and in vitro antiplasmodial activity of some bisquinolines against chloroquine-resistant strain.某些双喹啉类化合物对氯喹抗性菌株的设计、合成及体外抗疟活性
Chem Biol Drug Des. 2017 Jun;89(6):901-906. doi: 10.1111/cbdd.12914. Epub 2017 Jan 27.
5
Synthesis, Biological Evaluation, and Molecular Modeling Studies of Chiral Chloroquine Analogues as Antimalarial Agents.手性氯喹类似物作为抗疟药物的合成、生物评价和分子建模研究。
Antimicrob Agents Chemother. 2018 Nov 26;62(12). doi: 10.1128/AAC.02347-17. Print 2018 Dec.
6
Malagashanine potentiates chloroquine antimalarial activity in drug resistant Plasmodium malaria by modifying both its efflux and influx.马拉加沙宁通过改变氯喹的流出和流入,增强其对耐药疟原虫的抗疟活性。
Mol Biochem Parasitol. 2006 Mar;146(1):58-67. doi: 10.1016/j.molbiopara.2005.10.018. Epub 2005 Nov 17.
7
In vitro and in vivo chloroquine-potentiating action of Strychnos myrtoides alkaloids against chloroquine-resistant strains of Plasmodium malaria.铁屎米属生物碱对氯喹抗性疟原虫株的体外及体内氯喹增效作用
Planta Med. 1994 Feb;60(1):13-6. doi: 10.1055/s-2006-959398.
8
Design and synthesis of a new class of 4-aminoquinolinyl- and 9-anilinoacridinyl Schiff base hydrazones as potent antimalarial agents.新型4-氨基喹啉基和9-苯胺基吖啶基席夫碱腙作为高效抗疟剂的设计与合成
Chem Biol Drug Des. 2014 Aug;84(2):175-81. doi: 10.1111/cbdd.12289. Epub 2014 Mar 13.
9
Contrasting ex vivo efficacies of "reversed chloroquine" compounds in chloroquine-resistant Plasmodium falciparum and P. vivax isolates.“反向氯喹”化合物对氯喹耐药恶性疟原虫和间日疟原虫分离株的体外疗效对比
Antimicrob Agents Chemother. 2015 Sep;59(9):5721-6. doi: 10.1128/AAC.01048-15. Epub 2015 Jul 6.
10
Synthesis and antimalarial activity of new heterocyclic hybrids based on chloroquine and thiazolidinone scaffolds.基于氯喹和噻唑烷酮骨架的新型杂环杂合体的合成及抗疟活性。
Bioorg Med Chem. 2011 Aug 1;19(15):4562-73. doi: 10.1016/j.bmc.2011.06.025. Epub 2011 Jun 15.

引用本文的文献

1
Plasmodium yoelii as a model for malaria: insights into pathogenesis, drug resistance, and vaccine development.约氏疟原虫作为疟疾模型:对发病机制、耐药性及疫苗研发的见解
Mol Biol Rep. 2025 Feb 5;52(1):208. doi: 10.1007/s11033-025-10318-4.
2
CYP3A4-mediated metabolism of artemisinin to 10β-hydroxyartemisinin with comparable anti-malarial potency.CYP3A4 介导的青蒿素代谢为 10β-羟基青蒿素,具有相当的抗疟药效。
Malar J. 2024 Nov 5;23(1):328. doi: 10.1186/s12936-024-05163-y.
3
In vitro analyses of Artemisia extracts on Plasmodium falciparum suggest a complex antimalarial effect.

本文引用的文献

1
Synthesis and Evaluation of Chirally Defined Side Chain Variants of 7-Chloro-4-Aminoquinoline To Overcome Drug Resistance in Malaria Chemotherapy.7-氯-4-氨基喹啉手性定义侧链变体的合成与评价以克服疟疾化疗中的耐药性
Antimicrob Agents Chemother. 2017 Feb 23;61(3). doi: 10.1128/AAC.01152-16. Print 2017 Mar.
2
Synthesis of chiral chloroquine and its analogues as antimalarial agents.手性氯喹及其类似物作为抗疟剂的合成。
Bioorg Med Chem. 2014 Nov 1;22(21):5950-60. doi: 10.1016/j.bmc.2014.09.009. Epub 2014 Sep 16.
3
Synthesis and evaluation of new diaryl ether and quinoline hybrids as potential antiplasmodial and antimicrobial agents.
体外分析青蒿提取物对恶性疟原虫的作用表明其具有复杂的抗疟效果。
PLoS One. 2021 Mar 2;16(3):e0240874. doi: 10.1371/journal.pone.0240874. eCollection 2021.
4
Progress and challenges in the use of fluorescence-based flow cytometric assays for anti-malarial drug susceptibility tests.荧光流式细胞术检测抗疟药物敏感性试验的进展与挑战。
Malar J. 2021 Jan 21;20(1):57. doi: 10.1186/s12936-021-03591-8.
5
Metabolism of Piperaquine to Its Antiplasmodial Metabolites and Their Pharmacokinetic Profiles in Healthy Volunteers.哌喹在健康志愿者体内的代谢及其抗疟代谢产物的药代动力学特征。
Antimicrob Agents Chemother. 2018 Jul 27;62(8). doi: 10.1128/AAC.00260-18. Print 2018 Aug.
新型二芳基醚与喹啉杂化物作为潜在抗疟和抗菌剂的合成与评价
Bioorg Med Chem Lett. 2014 Apr 1;24(7):1719-23. doi: 10.1016/j.bmcl.2014.02.044. Epub 2014 Feb 27.
4
Synthesis and bioevaluation of novel 4-aminoquinoline-tetrazole derivatives as potent antimalarial agents.新型 4-氨基喹啉-四唑衍生物的合成与生物评价作为有效的抗疟药物。
Eur J Med Chem. 2013 Aug;66:69-81. doi: 10.1016/j.ejmech.2013.05.023. Epub 2013 May 28.
5
In-vitro culture of Plasmodium falciparum: utility of modified (RPNI) medium for drug-sensitivity studies using SYBR Green I assay.体外培养恶性疟原虫:使用 SYBR Green I 法进行药物敏感性研究的改良(RPNI)培养基的应用。
Exp Parasitol. 2011 Jan;127(1):318-21. doi: 10.1016/j.exppara.2010.08.007. Epub 2010 Aug 18.
6
Plasmodium falciparum: modified medium composition supports continuous cultivation with foetal bovine serum.恶性疟原虫:改良的培养基成分可支持在含胎牛血清的条件下连续培养。
Exp Parasitol. 2004 Sep-Oct;108(1-2):74-5. doi: 10.1016/j.exppara.2004.07.008.
7
Novel, rapid, and inexpensive cell-based quantification of antimalarial drug efficacy.新型、快速且廉价的基于细胞的抗疟药物疗效定量分析。
Antimicrob Agents Chemother. 2004 May;48(5):1807-10. doi: 10.1128/AAC.48.5.1807-1810.2004.
8
Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening.用于高通量抗疟药物筛选的简单且低成本的荧光技术。
Antimicrob Agents Chemother. 2004 May;48(5):1803-6. doi: 10.1128/AAC.48.5.1803-1806.2004.
9
A novel DNA-based microfluorimetric method to evaluate antimalarial drug activity.一种基于DNA的新型微量荧光法用于评估抗疟药物活性。
Am J Trop Med Hyg. 2004 Feb;70(2):119-24.
10
The assessment of antimalarial drug efficacy.抗疟药物疗效的评估。
Trends Parasitol. 2002 Oct;18(10):458-64. doi: 10.1016/s1471-4922(02)02373-5.